NOVAMSC-PA Stock Overview
An investment holding company, engages in the software research and development, and provision of e-business solutions in Malaysia and Singapore.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Nova MSC Berhad Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | RM 0.09 |
| 52 Week High | RM 0.25 |
| 52 Week Low | RM 0.04 |
| Beta | 1.08 |
| 11 Month Change | -18.18% |
| 3 Month Change | -41.94% |
| 1 Year Change | 20.00% |
| 33 Year Change | 20.00% |
| 5 Year Change | n/a |
| Change since IPO | 1,700.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| NOVAMSC-PA | MY Software | MY Market | |
|---|---|---|---|
| 7D | 0% | -2.2% | 0.2% |
| 1Y | 20.0% | -19.8% | 10.2% |
Return vs Industry: NOVAMSC-PA exceeded the MY Software industry which returned -19.2% over the past year.
Return vs Market: NOVAMSC-PA exceeded the MY Market which returned 10.4% over the past year.
Price Volatility
| NOVAMSC-PA volatility | |
|---|---|
| NOVAMSC-PA Average Weekly Movement | 19.9% |
| Software Industry Average Movement | 7.1% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in MY Market | 10.8% |
| 10% least volatile stocks in MY Market | 3.0% |
Stable Share Price: NOVAMSC-PA's share price has been volatile over the past 3 months compared to the MY market.
Volatility Over Time: NOVAMSC-PA's weekly volatility (20%) has been stable over the past year, but is still higher than 75% of MY stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | n/a | Teik Kin Lai | www.nova-hub.com |
Nova MSC Berhad, an investment holding company, engages in the software research and development, and provision of e-business solutions in Malaysia and Singapore. Its product portfolio includes Pavo, a software that facilities the online submission of application documents; and Fornax, an electronic plan check systems and electronic approval management software. The company also offers Vesalius, a web-based platform that supports the administrative and clinical function within a hospital, including physician support systems, nursing care, disease management, scheduling, patient registration, operating theatre management, and billing; Avicenna, an integrated cloud-based system, which manages the administrative needs and clinical aspects of patient management in a healthcare facility from a single practitioner clinic to a multi-specialist outpatient center; and EyScan, a cloud based platform, which manages and execute SELENA+ that performs automated retinal photo analysis to detect retinopathy and systemic complications in diabetic patients.
Nova MSC Berhad Fundamentals Summary
| NOVAMSC-PA fundamental statistics | |
|---|---|
| Market cap | RM 169.66m |
| Earnings (TTM) | -RM 7.15m |
| Revenue (TTM) | RM 34.88m |
5.1x
P/S Ratio-24.7x
P/E RatioIs NOVAMSC-PA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NOVAMSC-PA income statement (TTM) | |
|---|---|
| Revenue | RM 34.88m |
| Cost of Revenue | RM 27.72m |
| Gross Profit | RM 7.16m |
| Other Expenses | RM 14.31m |
| Earnings | -RM 7.15m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0051 |
| Gross Margin | 20.52% |
| Net Profit Margin | -20.50% |
| Debt/Equity Ratio | 26.3% |
How did NOVAMSC-PA perform over the long term?
See historical performance and comparison